Natural Selections

Seven wonder drugs that do grow on trees.

Illustration: Bettmann/Corbis

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

As much as three-quarters of the drugs approved to treat infectious disease and cancer over the past 25 years originated with chemicals or compounds first found in nature. Which means that last acre of rainforest or ocean floor might contain ever more promising cures. A few notable pharmaceuticals that got their start outside the laboratory:

ASPIRIN In the fifth century BC, Hippocrates noted willow bark’s ability to fight fevers and pain. A chemical found in the bark became the key ingredient of aspirin, patented in 1900.

QUININE Indigenous Peruvians used the bark of the cinchona tree to cure fevers. European scientists isolated its antimalarial ingredient in the early 19th century.

LOVASTATIN This chemical, found in the fungus Aspergillus terreus and oyster mushrooms, reduces LDL “bad” cholesterol. In 1987 it became the first FDA-approved statin.

CALANOLIDE A In the late 1980s, a rare tree from Borneo was found to have antiretroviral properties. Still in trials, the resulting drug has shown promise in combating HIV.

TAXOL Tumor-fighting compound derived from the bark of the Pacific yew, introduced as a cancer drug in 1993. It’s since been found in some mushrooms and mycelia.

YONDELIS A cancer drug modeled after an agent discovered in a Caribbean sea squirt. Currently available only in the EU.

PRIALT In 2004, Elan Pharmaceuticals unveiled this drug for treating chronic pain, made from synthetic sea-snail venom. The drug’s logo is a snail shell.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend